Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Geissler

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Wiener Klinische Wochenschrift|September 19, 2003
Pathophysiology and treatment of aplastic anemiaKlaus Geissler
Wiener Medizinische Wochenschrift (1946)|August 26, 2025
Bioinformatic analysis of big data in chronic myelomonocytic leukemia (CMML)Klaus Geissler
Wiener Medizinische Wochenschrift (1946)|January 25, 2023
Chronic myelomonocytic leukemia (CMML)Klaus Geissler
Expert Review of Anticancer Therapy|December 25, 2012
A shared fight against cancer: the complementary roles of oncology physicians and oncology pharmacistsKlaus Geissler
Wiener Medizinische Wochenschrift (1946)|September 11, 2014
Translational hematologyKlaus Geissler
Frontiers in Oncology|October 18, 2021
Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment ApproachesKlaus Geissler
Annals of Hematology|March 16, 2012
Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathwayKlaus Geissler, Otto Zach
Wiener Medizinische Wochenschrift (1946)|March 5, 2025
Features of TP53-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBIOPORTAL)Magdalena Grass, Klaus Geissler
Wiener Medizinische Wochenschrift (1946)|October 25, 2022
Significance of reduced renal function in patients with chronic myelomonocytic leukemiaJulia Heschl, Klaus Geissler
Wiener Medizinische Wochenschrift (1946)|June 23, 2025
Features of SRSF2-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBioPortal)Marc Tölly, Klaus Geissler
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Wiener Klinische Wochenschrift|September 19, 2003
Pathophysiology and treatment of aplastic anemiaKlaus Geissler
Wiener Medizinische Wochenschrift (1946)|August 26, 2025
Bioinformatic analysis of big data in chronic myelomonocytic leukemia (CMML)Klaus Geissler
Wiener Medizinische Wochenschrift (1946)|January 25, 2023
Chronic myelomonocytic leukemia (CMML)Klaus Geissler
Expert Review of Anticancer Therapy|December 25, 2012
A shared fight against cancer: the complementary roles of oncology physicians and oncology pharmacistsKlaus Geissler
Wiener Medizinische Wochenschrift (1946)|September 11, 2014
Translational hematologyKlaus Geissler
Frontiers in Oncology|October 18, 2021
Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment ApproachesKlaus Geissler
Annals of Hematology|March 16, 2012
Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathwayKlaus Geissler, Otto Zach
Wiener Medizinische Wochenschrift (1946)|March 5, 2025
Features of TP53-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBIOPORTAL)Magdalena Grass, Klaus Geissler
Wiener Medizinische Wochenschrift (1946)|October 25, 2022
Significance of reduced renal function in patients with chronic myelomonocytic leukemiaJulia Heschl, Klaus Geissler
Wiener Medizinische Wochenschrift (1946)|June 23, 2025
Features of SRSF2-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBioPortal)Marc Tölly, Klaus Geissler
Pageof 12